08-Jan-2019 | Zion Market Research
Zion Market Research has published a new report titled “Particle Therapy Market by Type (Heavy Ion Therapy and Proton Therapy), by System (Single-Room and Multi-Room), by Product (Cyclotrons, Synchrocyclotrons, and Synchrotrons), by Cancer Type (Pediatric Cancer, Breast Cancer, Prostate Cancer, Head and Neck Cancer, Lung Cancer, and Others), and by Application (Research Applications and Treatment Applications): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024”. According to the report, the global particle therapy market was valued at approximately USD 770 million in 2017 and is expected to generate around USD 1439 million by 2024, at a CAGR of around 9.5% between 2018 and 2024.
Particle therapy uses rays of charged positive ions, neutrons, or protons for cancer treatment. Particle therapy is a revolutionary domain of external beam radiotherapy, which combines research in physics and its application in the field of oncology. It has the potential to cure some short and long-term complications. The non-invasive characteristic of particle therapy is a major advantage that can result in more patients receiving the treatment. Carbon ion beams are most often used for treating cancer. Proton therapy is the most popular type of particle therapy. It uses proton beams to irradiate affected tissue. Proton therapy employs ionizing radiation. A particle accelerator is used in proton therapy to aim tumors with proton beams.
Browse the full “Particle Therapy Market by Type (Heavy Ion Therapy and Proton Therapy), by System (Single-Room and Multi-Room), by Product (Cyclotrons, Synchrocyclotrons, and Synchrotrons), by Cancer Type (Pediatric Cancer, Breast Cancer, Prostate Cancer, Head and Neck Cancer, Lung Cancer, and Others), and by Application (Research Applications and Treatment Applications): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024 ” Report at https://www.zionmarketresearch.com/report/particle-therapy-market
Increasing incidences of cancer, rising use of particle therapy in clinical trials, multiple advantages of particle therapy, the growing number of particle therapy hubs globally, increasing usage of tobacco in some regions, rising per capita healthcare expenditure, and increasing geriatric population are likely to be the growth drivers of the global particle therapy market. Rising worldwide awareness regarding particle therapy and increasing investments by major players are likely to create new growth opportunities for the market players. However, challenges faced by the healthcare sector regarding infrastructure, accessibility, affordability of treatments, restricted insurance cover for particle therapy, and unfavorable reimbursement policies might restrict the particle therapy market globally in the future.
The global particle therapy market is segmented based on type, system, product, cancer type, and application. By type, this market includes heavy ion therapy and proton therapy. By system, the market includes single-room and multi-room systems. By product, the market includes cyclotrons, synchrocyclotrons, and synchrotrons. By cancer type, this market includes pediatric cancer, breast cancer, prostate cancer, head and neck cancer, lung cancer, and others. By application, this market includes research applications and treatment applications.
By region, this global market includes North America, Latin America, Europe, the Middle East, and Africa, and the Asia Pacific. The Asia Pacific region is likely to lead this global market in the future, owing to the growing healthcare expenditure, a rising number of initiatives for the promotion of latest particle therapy usage, and increasing incidences of cancer. North America is likely to be the second largest particle therapy market in the upcoming years, due to technological advancements related to particle therapy, availability of advanced treatment, adoption of latest diagnostic technologies, and high per capita healthcare expenditure. The European particle therapy market is anticipated to grow rapidly over the estimated timeframe, owing to the availability of the latest healthcare infrastructure and growing cancer prevalence in the region.
Some key players of the particle therapy market include Varian Medical Systems, Inc., Ion Beam Applications SA, Hitachi, Ltd., Mevion Medical Systems, Inc., Provision Healthcare, Sumitomo Heavy Industries, Ltd., ProTom International, Inc., Optivus Proton Therapy, Inc., Danfysik A/S, and Advanced Oncotherapy Plc, among others.
This report segments the global particle therapy market into:
Global Particle Therapy Market: By Type
Global Particle Therapy Market: By System
Global Particle Therapy Market: By Product
Global Particle Therapy Market: By Cancer Type
Global Particle Therapy Market: By Application
Global Particle Therapy Market: By Region
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651